LOBEF (Lobe Sciences) Other Stockholders Equity: $0.10 Mil (As of Feb. 2026)


What is Lobe Sciences Other Stockholders Equity?

Lobe Sciences LOBEF +2.81% Other Stockholders Equity is $0.10 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Lobe Sciences's Other Stockholders Equity for the quarter that ended in Feb. 2026 was $0.10 Mil.

Lobe Sciences's quarterly Other Stockholders Equity increased from Aug. 2025 ($0.00 Mil) to Nov. 2025 ($0.10 Mil) and increased from Nov. 2025 ($0.10 Mil) to Feb. 2026 ($0.10 Mil).

Lobe Sciences's annual Other Stockholders Equity declined from Aug. 2023 ($1.45 Mil) to Aug. 2024 ($0.00 Mil) and declined from Aug. 2024 ($0.00 Mil) to Aug. 2025 ($0.00 Mil).

Lobe Sciences Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Other Stockholders Equity Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.12 3.80 1.45 0.00 0.00

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.26 0.00 0.10 0.10

Lobe Sciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.10 Mil mean?
Lobe Sciences (LOBEF) has a Other Stockholders Equity of $0.10 Mil as of Feb. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lobe Sciences and its competitors.
Is Lobe Sciences' Other Stockholders Equity too high?
Lobe Sciences' current Other Stockholders Equity is $0.10 Mil.
How does Lobe Sciences' Other Stockholders Equity compare to VRTX and REGN?
Lobe Sciences' Other Stockholders Equity of $0.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current Other Stockholders Equity is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Other Stockholders Equity of $0.10 Mil. The current Other Stockholders Equity is $0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Other Stockholders Equity is $0.10 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.